Skyrizi (risankizumab)

pCPA File Number: 22367
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of adults with moderately to severely active Crohn's disease
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
SR0767
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable